Novolin 70/30

Indicated For

Diabetes

About This Medication

# Novo Nordisk Patient Assistance Program (PAP) Patient Guide: How to Get Novolin 70/30 (insulin NPH regular human) at Low or No Cost This guide explains how to apply for free **Novolin 70/30** through the Novo Nordisk Patient Assistance Program (PAP). It provides **insulin NPH regular human** at no cost to eligible patients, helping manage diabetes without high out-of-pocket expenses.[1] ## About Novolin 70/30 **Novolin 70/30** is a premixed insulin combining 70% intermediate-acting NPH insulin and 30% short-acting regular insulin. It helps control blood sugar levels in adults and children with diabetes mellitus. Administered via subcutaneous injection, it starts working in 1-2 hours, peaks in 4-12 hours, and lasts up to 24 hours. Always follow your healthcare provider's dosing instructions, monitor blood glucose regularly, and store unopened vials in the refrigerator.[1][2] ## Who Qualifies for the Program? The Novo Nordisk PAP offers free medication to uninsured or Medicare Part D patients meeting income and residency rules. You must be a U.S. citizen or legal resident. Key requirements include: - **Income limits**: For 2026, uninsured patients need household income at or below **200% of the Federal Poverty Level (FPL)** and a Medicaid denial letter. Medicare patients on insulins require income below **150% FPL** with a Part D Extra Help (LIS) denial. Specific product eligibility applies; check if **Novolin 70/30** remains covered as some insulins like unbranded ones are excluded in 2026.[1][4] - No registration or monthly fees.[1] - Not eligible if enrolled in Medicaid or other federal programs (denial proof required).[1][4] **Note**: Eligibility details vary by product and year. **Novolin 70/30** coverage for 2026 should be verified on the application site, as unbranded insulins are being phased out.[4] ## Income Eligibility Breakdown Income thresholds are based on **Federal Poverty Level (FPL)**, updated annually. Here's a table for 2026 estimates (visit NeedyMeds for exact figures): | Household Size | Uninsured (≤200% FPL) | Medicare Insulins (≤150% FPL) | |----------------|-----------------------|-------------------------------| | 1 person | ~$30,000 | ~$22,590 | | 2 people | ~$40,500 | ~$30,660 | | 3 people | ~$51,000 | ~$38,730 | | 4 people | ~$61,500 | ~$46,800 | *Add ~$10,500 (200%) or ~$8,070 (150%) per additional person. Proof of total household income required.[4][7] ## Insurance Requirements - **Uninsured**: Eligible with income ≤200% FPL and Medicaid denial letter.[4] - **Medicare Part D**: No $1,000 out-of-pocket spend required anymore. Valid through December 31 of approval year; income ≤150% FPL for insulins with LIS denial.[1][2][4] - **Medicaid/Medicare LIS**: Must submit denial letter; not eligible if enrolled.[1] - Cannot be on other federal/state programs.[2] ## Step-by-Step Application Process 1. **Visit the website**: Go to the [NovoCare PAP page](https://www.novocare.com/diabetes/help-with-costs/pap.html).[1] 2. **Complete patient portion**: Enter personal info, household income, insurance status, and your healthcare provider's (HCP) email.[1] 3. **HCP completes their part**: They receive a secure email link to verify prescription and details.[1][2] 4. **Upload documents**: Provide proof of income (pay stubs, tax returns), Medicaid/Medicare LIS denial (if applicable), government ID, and HCP prescription.[1] 5. **Submit online**: Application is digital; Spanish version coming soon.[1] Processing takes **2 business days** if complete.[1] ## Timeline and Delivery - **Approval notification**: Mailed letter; opt for automated phone/text alerts.[1] - **Delivery**: Shipped free to your home by **Neovance Specialty Pharmacy** (call 1-800-488-5908 to schedule).[2] - **Supply**: Up to 120-day supply; automatic refills if eligible.[2] - **Validity**: 12 months for uninsured; calendar year for Medicare Part D.[2] - **Reauthorization**: Renew annually online after October 15 for Medicare; new prescriber needs new application.[2] ## Alternatives if Denied or Ineligible - **Other Novo Nordisk programs**: Insulin affordability options at NovoCare.[1][4][6] - **Extra Help (LIS)**: Apply for Medicare low-income subsidy.[4] - **State Medicaid**: Check eligibility; appeal denials.[4] - **NeedyMeds/RxAssist**: Search additional PAPs or copay cards.[7][8] - **Manufacturer savings cards**: For insured patients (not PAP-eligible).[6] - **Community clinics**: Free/low-cost insulin via 340B programs or pharmacies. If **Novolin 70/30** is excluded in 2026, alternatives like Tresiba or NovoLog may be available.[4] ## Important Disclaimer This guide is for informational purposes based on 2026 program details and may change. Novo Nordisk reserves the right to modify or cancel PAP without notice. Verify current eligibility, product coverage (**Novolin 70/30** status), and FPL on official sites. Consult your HCP before changing insulin. Not medical advice; individual results vary.[1][2][4]

Program information last verified: March 30, 2026